Genmab A/S (GMAB) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 3.9% on average (either way), rising 7 times and falling 5. EPS beat estimates 8 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-05 | 36.82 | 23.32 | +57.9% | 7.93B | 7.92B | -1.4% |
| Q2 FY2026 | 2026-08-06 | 31.78 | 23.36 | +36.0% | 7.48B | 7.33B | +5.7% |
| Q1 FY2026 | 2026-05-07 | 5.27 | 10.10 | -47.8% | 5.69B | 5.87B | -7.2% |
| Q4 FY2025 | 2026-02-17 | 3.14 | 17.89 | -82.4% | 6.69B | 6.80B | -2.5% |
| Q3 FY2025 | 2025-11-06 | 41.79 | 31.44 | +32.9% | 41.55B | 6.41B | +0.5% |
| Q2 FY2025 | 2025-08-07 | 34.65 | 25.51 | +35.8% | 5.86B | 5.78B | +0.4% |
| Q1 FY2025 | 2025-05-08 | 20.26 | 15.81 | +28.1% | 4.93B | 4.91B | -3.3% |
| Q4 FY2024 | 2025-02-12 | 58.84 | 22.26 | +164.3% | 6.44B | 6.29B | +8.6% |